{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:05:50Z","timestamp":1778918750899,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ccl.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T02:19:00Z","timestamp":1600222740000},"page":"589-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bioresorbable Coronary Scaffold Technologies"],"prefix":"10.1016","volume":"38","author":[{"given":"Giulia","family":"Masiero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Rodin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juji","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2020.07.004_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccl.2020.07.004_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.116.021539","article-title":"Bioresorbable vascular scaffolds for coronary revascularization","volume":"134","author":"Kereiakes","year":"2016","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.004_bib3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/CIRCULATIONAHA.119.043773","article-title":"Bioresorbable scaffolds: unfulfilled prophecies","volume":"140","author":"Raber","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ccl.2020.07.004_bib4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.4244\/EIJ20170912-01","article-title":"Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary","volume":"13","author":"Byrne","year":"2018","journal-title":"Eurointervention"},{"key":"10.1016\/j.ccl.2020.07.004_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ijcard.2016.11.258","article-title":"Bioresorbable stents: current and upcoming bioresorbable technologies","volume":"228","author":"Ang","year":"2017","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2020.07.004_bib6","first-page":"419","article-title":"The BVS concept. From the chemical structure to the vascular biology: the bases for a change in interventional cardiology","volume":"64","author":"Tarantini","year":"2016","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.ccl.2020.07.004_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2018.01.063","article-title":"\"Full-plastic jacket\" with everolimus-eluting Absorb bioresorbable vascular scaffolds: clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413)","volume":"266","author":"Tarantini","year":"2018","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.004_bib8","first-page":"E1","article-title":"Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: an analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413)","volume":"91","author":"Tarantini","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10018","key":"10.1016\/j.ccl.2020.07.004_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bio- resorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ccl.2020.07.004_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.carrev.2019.04.013","volume":"20","author":"Chang","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ccl.2020.07.004_bib11","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","article-title":"Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial","volume":"392","author":"Stone","year":"2018","journal-title":"Lancet"},{"issue":"10096","key":"10.1016\/j.ccl.2020.07.004_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","article-title":"2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy","volume":"390","author":"Ali","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.004_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.117.031843","article-title":"Three-Year outcomes with the ab- sorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials","volume":"137","author":"Ali","year":"2018","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.ccl.2020.07.004_bib14","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4244\/EIJ-D-17-00492","article-title":"Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials","volume":"13","author":"Cassese","year":"2018","journal-title":"Eurointervention"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.004_bib15","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/CIRCULATIONAHA.119.042584","article-title":"Clinical outcomes before and after complete everolimus-eluting bioresorbable scaffold resorption: five-year follow-up from the ABSORB III trial","volume":"140","author":"Kereiakes","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.004_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcin.2019.09.047","article-title":"Randomized comparison between everolimus-eluting bioresorbable scaffold and metallic stent: multimodality imaging through 3 years","volume":"13","author":"Onuma","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"Suppl. S9","key":"10.1016\/j.ccl.2020.07.004_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.21037\/jtd.2017.07.25","article-title":"The DESolve novolimus bioresorbable Scaffold: from bench to bedside","volume":"9","author":"Mattesini","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"issue":"18","key":"10.1016\/j.ccl.2020.07.004_bib18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jcin.2017.07.033","article-title":"6-month clinical and angiographic outcomes of a novel radiopaque sirolimus-eluting bioresorbable vascular scaffold: the FANTOM II study","volume":"10","author":"Abizaid","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.ccl.2020.07.004_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2017.03.015","article-title":"Randomized comparison of absorb bioresorbable vascular scaffold and mirage microfiber sirolimus-eluting scaffold using multimodality imaging","volume":"10","author":"Tenekecioglu","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"Suppl 9","key":"10.1016\/j.ccl.2020.07.004_bib20","doi-asserted-by":"crossref","first-page":"S979","DOI":"10.21037\/jtd.2017.07.104","article-title":"New generation bioresorbable scaffold technologies: an update on novel devices and clinical results","volume":"9","author":"Regazzoli","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"issue":"9","key":"10.1016\/j.ccl.2020.07.004_bib21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/17434440.2019.1649133","article-title":"Magmaris resorbable magnesium scaffold for the treatment of coronary heart disease: overview of its safety and efficacy","volume":"16","author":"Bennett","year":"2019","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.ccl.2020.07.004_bib22","article-title":"Mechanical properties of the drug-eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug-eluting stent","author":"Barkholt","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.ccl.2020.07.004_bib23","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.4244\/EIJ-D-18-01000","article-title":"Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in- man trial","volume":"15","author":"Haude","year":"2020","journal-title":"Eurointervention"},{"key":"10.1016\/j.ccl.2020.07.004_bib24","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ehjci\/jey210","article-title":"Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions: an optical coherence tomography analysis","volume":"20","author":"Ozaki","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"15","key":"10.1016\/j.ccl.2020.07.004_bib25","doi-asserted-by":"crossref","first-page":"e1383","DOI":"10.4244\/EIJ-D-18-01058","article-title":"Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry","volume":"15","author":"Verheye","year":"2020","journal-title":"Eurointervention"},{"issue":"23","key":"10.1016\/j.ccl.2020.07.004_bib26","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.119.043467","article-title":"Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI randomized clinical trial","volume":"140","author":"Sabat\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.004_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4244\/EIJ-D-18-00607","article-title":"How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials","volume":"15","author":"Katagiri","year":"2019","journal-title":"Eurointervention"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.004_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcin.2019.10.049","article-title":"Understanding the bioresorbable vascular scaffold Achilles heel: insights from ABSORB Japan Serial Intracoronary Imaging","volume":"13","author":"Raber","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2020.07.004_bib29","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/ehv581","article-title":"Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms","volume":"37","author":"Gori","year":"2016","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ccl.2020.07.004_bib30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors","volume":"67","author":"Puricel","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2020.07.004_bib31","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.jacc.2017.09.1106","article-title":"Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials","volume":"70","author":"Stone","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2020.07.004_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcin.2016.12.279","article-title":"Antiplatelet therapy after implantation of Bioresorbable vascular scaffolds: a review of the published data, practical recommendations, and future directions","volume":"10","author":"Capodanno","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ccl.2020.07.004_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.carrev.2019.10.012","article-title":"Second-generation drug-eluting resorbable magnesium scaffold: review of the clinical evidence","volume":"21","author":"Ozaki","year":"2020","journal-title":"Cardiovasc Revasc Med"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865120300606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865120300606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:52:12Z","timestamp":1760007132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865120300606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0733865120300606"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2020.07.004","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioresorbable Coronary Scaffold Technologies","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}